To, Kenneth Kin-Wah
Name
To, Kenneth Kin-Wah
Loading...
4
0
5
0
false
Results 1-3 of 3
| Issue Date | Title | Author(s) | Type | |
|---|---|---|---|---|
| 1 | 2025 | Fexofenadine overcomes osimertinib resistance by inhibiting c-Met in non-small cell lung cancer | To, Kenneth Kin-Wah ; Prof. LEUNG Kwong Sak ; Cho, William C. | Peer Reviewed Journal Article |
| 2 | 2023 | MET-targeting anticancer drugs—de novo design and identification by drug repurposing | To, Kenneth Kin-Wah ; Prof. LEUNG Kwong Sak ; Cho, William Chi Shing | Peer Reviewed Journal Article |
| 3 | 2017 | Identification of clinically approved drugs indacaterol and canagliflozin for repurposing to treat epidermal growth factor tyrosine kinase inhibitor-resistant lung cancer | Li, Hongjian ; Tong, Christy Wing-Sum ; Leung, Yee ; Wong, Man-Hon ; To, Kenneth Kin-Wah ; Prof. LEUNG Kwong Sak | Peer Reviewed Journal Article |